Ascendis Pharma A/S (ASND)

134,00 -3,20 (-2,33%) Al cierre: 04:00PM EDT

Ascendis Pharma A/S

Tuborg Boulevard 12
Hellerup 2900
Denmark
45 70 22 22 44
https://ascendispharma.com

Sector(es): Healthcare
Sector: Biotechnology
Empleados a tiempo completo: 879

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Jan Moller Mikkelsen	President, CEO, Member of Executive Board & Executive Director	N/A	N/A	1960
Mr. Scott T. Smith	CFO, Executive VP & Member of Executive Board	N/A	N/A	1974
Ms. Lotte Sonderbjerg	Executive VP, Chief Administrative Officer & Member of the Executive Board	N/A	N/A	1961
Mr. Michael Wolff Jensen L.L.M.	Executive VP, Chief Legal Officer & Member of the Executive Board	N/A	N/A	1971
Mr. Mads Bodenhoff	Senior VP of Finance & Principal Accounting Officer	N/A	N/A	N/A
Mr. Timothy J. Lee	Senior Director of Investor Relations	N/A	N/A	N/A
Mr. Flemming Steen Jensen	Executive Vice President of Product Supply & Quality	N/A	N/A	1961
Dr. Kennett Sprogoe Ph.D.	Executive VP and Head of Research & Product Development	N/A	N/A	1979
Dr. Stina Singel M.D., Ph.D.	Executive VP & Head of Clinical Development for Oncology	N/A	N/A	1974
Mr. Joseph Kelly	Head of U.S. Commercial of Endocrinology	N/A	N/A	1969

Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Gobierno corporativo

El ISS Governance QualityScore de Ascendis Pharma A/S, a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.